,
your personalized virtual assistant to find clinical trials. Go head, 
Kevan Herold, MD
Yale UniversityNew Haven, Connecticut - 06504 ((203) 688-7987) Yale University School of MedicineNew Haven, Connecticut - 06519 (203-974-7043) |
- CLINICAL TRIALS 5
- CONDITIONS2
- INTERVENTIONS5
- SINCE2004
Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes
August 2007 - June 2015
Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
September 2006 - June 2012
A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I
October 2010 - November 2014
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
February 2007 - February 2014
Natural History Study of the Development of Type 1 Diabetes
February 2004 - June 2014
Diabetes Mellitus
Diabetes Mellitus, Type 1
Placebo
Antithymocyte Globulin
Mab Hokt3gamma1(Ala-Ala), Teplizumab
Alpha 1-Antitrypsin (Aat, Aralast Np)
Oral Insulin
